MAPT and Alzheimer disease: Considering that regional tau deposition in AD correlates with clinical symptoms and this abnormal pattern of tau deposition correlates with the Braak Stages, [18F]PI-2620 can be assumed to be clinically useful for the detection of tau deposits in specific brain regions.